semaglutide and gastric emptying as a GLP-1 Agonist: A Breakthrough in Obesity Treatment Does Ozempic Cause Gastroparesis? [2026

This means that your body will absorb less of the oral medication than it would absorb of the injectable form

This is why lifestyle changes such as a healthy diet and regular physical activity are essential to maintain results

Semaglutide for weight management (Wegovy) is FDA-approved only for adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia

Once prescribed, injections are typically self-administered at home with your providers guidance, though support is always available if needed

After exhaustive review of the costs and consideration of long-term impacts and effectiveness of the drug, we believe that this is the right decision

WHAT IT DOES